Reiter’s Syndrome (Reactive Arthritis)
Overview
Reiter’s syndrome, more accurately called reactive arthritis, is an inflammatory joint disease that develops in response to an infection elsewhere in the body—most often the gastrointestinal or genitourinary tract. The condition usually appears 1–4 weeks after the initial infection and is characterized by a triad of symptoms:
- Arthritis (joint pain and swelling)
- Conjunctivitis or uveitis (eye inflammation)
- Urethritis (painful urination) or cervicitis
Reactive arthritis can affect people of any age, but it is most common in adults aged 20–40 years. Men are slightly more likely to develop the disease than women (approximately 1.5:1 ratio) and individuals who carry the genetic marker HLA‑B27 have a 30–50 % higher risk.
Worldwide prevalence is low, estimated at **0.2–1.0 cases per 1,000 persons**. In the United States, about **30,000–40,000 new cases** are diagnosed each year, largely following outbreaks of chlamydia, salmonella, shigella, or campylobacter infections.[1][2]
Symptoms
The clinical picture is highly variable. Symptoms may appear gradually or suddenly and can wax and wane over months or years. Below is a comprehensive list with short descriptions.
Joint (Articular) Manifestations
- Asymmetric oligoarthritis – typically 1‑4 large joints (knees, ankles, feet, or hips) on one side of the body.
- Sacroiliitis – inflammation of the sacroiliac joint causing low‑back or buttock pain.
- Enthesitis – pain at tendon or ligament insertions, most frequently at the Achilles tendon or plantar fascia.
- Dactylitis (“sausage digit”) – swelling of an entire finger or toe.
Eye Involvement
- Conjunctivitis – red, gritty eyes, tearing, photophobia.
- Uveitis – deeper eye inflammation that can cause blurred vision and light sensitivity; requires urgent ophthalmic evaluation.
Genitourinary Symptoms
- Urethritis – burning on urination, discharge, or pelvic pain.
- Cervicitis or vaginal discharge in women.
Skin and Mucosal Findings
- Keratoderma blennorrhagicum – hyperkeratotic, pustular lesions on soles and palms.
- Calcium phosphate (chalky) deposits on tendons, called “calcaneal spurs.”
- Oral ulcers and circinate balanitis (painless shallow ulcer on the glans penis).
Systemic Features
- Fever, malaise, and fatigue during the acute phase.
- Low back pain that mimics ankylosing spondylitis.
- Elevated inflammatory markers (ESR, CRP).
Causes and Risk Factors
Reactive arthritis is not caused by the arthritis‑producing organism itself; rather, it is an **immune‑mediated response** to an infection that has typically been cleared from the primary site.
Typical Triggering Infections
- Chlamydia trachomatis – the most common sexually transmitted trigger.
- Salmonella, Shigella, Yersinia, Campylobacter – foodborne gastrointestinal pathogens.
- Clostridium difficile – increasingly recognized, especially after antibiotic use.
Genetic Predisposition
The HLA‑B27 antigen is present in 50–80 % of patients with reactive arthritis, compared with 8 % of the general population. The exact mechanism is unclear, but it appears to promote abnormal immune recognition of bacterial antigens.
Additional Risk Factors
- Male sex (especially < 40 y).
- Recent gastrointestinal or genitourinary infection (within 1‑4 weeks).
- History of previous reactive arthritis episodes (recurrence is possible).
- Smoking – weakly linked to more severe disease.
- Co‑existing inflammatory bowel disease (IBD) or psoriasis.
Diagnosis
Because there is no single laboratory test that confirms reactive arthritis, diagnosis relies on a combination of clinical criteria, exclusion of other diseases, and targeted laboratory work‑up.
Clinical Criteria (Modified Maastricht/Calgary)
- Evidence of a preceding infection (documented or strongly suspected).
- Arthritis (usually asymmetric, oligoarticular) lasting >1 month.
- At least one extra‑articular feature (conjunctivitis, urethritis, or enthesitis).
- Absence of an alternative diagnosis such as septic arthritis or gout.
Laboratory & Imaging Studies
- Blood tests: CBC (often normal), ESR & CRP (elevated), rheumatoid factor (negative in most cases), anti‑CCP (negative).
- Infection screening: Urine NAAT for Chlamydia, stool culture or PCR for Salmonella/Shigella/Yersinia.
- HLA‑B27 typing: Positive result supports diagnosis but is not required.
- Joint aspiration (if effusion present) – to rule out septic arthritis; synovial fluid is usually non‑infectious.
- Imaging: X‑ray early may be normal; later shows joint space narrowing or erosions. MRI can detect sacroiliitis or enthesitis.
Treatment Options
Treatment aims to control inflammation, relieve pain, and prevent long‑term joint damage. Therapy is usually staged, beginning with the least aggressive options.
1. Non‑pharmacologic Measures
- Rest the affected joint(s) for the first 48–72 hours, then begin gentle range‑of‑motion exercises.
- Ice packs (15 min, 3–4 times/day) to reduce swelling.
- Physical therapy focusing on strengthening, stretching, and gait training.
- Smoking cessation and weight management to lower mechanical stress on joints.
2. First‑Line Medications
- NSAIDs (ibuprofen, naproxen, diclofenac) – reduce pain and inflammation; use the lowest effective dose for the shortest duration.
- Acetaminophen – adjunct for pain when NSAIDs are contraindicated.
3. Disease‑Modifying Options
- Intra‑articular corticosteroid injection – for persistent mono‑ or oligoarticular disease.
- Systemic corticosteroids (prednisone 10‑20 mg/day) – short courses (≤2 weeks) for severe flares.
- DMARDs (Disease‑Modifying Antirheumatic Drugs) – sulfasalazine or methotrexate when arthritis is chronic (>3 months) or refractory to NSAIDs.
4. Biologic Therapy
For patients who fail conventional DMARDs, tumor necrosis factor (TNF) inhibitors (etanercept, infliximab, adalimumab) have demonstrated efficacy in reducing joint and eye inflammation.[3] These agents require specialist monitoring for infection risk.
5. Antibiotic Considerations
Routine antibiotics after the initial infection have not consistently prevented arthritis and are not recommended for most cases. However, if Chlamydia infection is still active (positive NAAT), a full course of doxycycline (100 mg bid for 14 days) is indicated.[4]
6. Lifestyle & Supportive Care
- Regular low‑impact aerobic activity (walking, swimming) to maintain joint mobility.
- Orthopedic shoes or custom insoles for enthesitis of the foot.
- Eye drops or topical steroids for mild conjunctivitis; oral steroids or ophthalmology referral for uveitis.
- Psychological support or counseling if chronic pain impacts mental health.
Living with Reiter’s Syndrome (Reactive Arthritis)
While many patients experience remission within 6–12 months, up to 30 % develop a chronic or recurrent course. Long‑term self‑management is essential.
Daily Management Tips
- Joint protection – use cushioned footwear, avoid prolonged standing, and employ ergonomic tools.
- Exercise routine – 20‑30 minutes of gentle stretching and strengthening 3–4 times weekly; consider yoga or Pilates.
- Heat & cold therapy – warm showers or heating pads before activity; ice after activity.
- Medication adherence – take NSAIDs with food, schedule DMARD doses at the same time each day.
- Monitor eye symptoms – any sudden vision change warrants prompt ophthalmology review.
- Track flare triggers – keep a diary of infections, stress, diet, and symptom patterns.
- Vaccinations – stay up‑to‑date on flu and pneumococcal vaccines; avoid live vaccines when on high‑dose immunosuppressants.
Support Resources
- Arthritis Foundation (www.arthritis.org)
- American College of Rheumatology patient education portal
- Local support groups for chronic inflammatory arthritis
Prevention
Because reactive arthritis follows an infection, preventing the initial illness is the most effective strategy.
- Safe sexual practices – consistent condom use, regular STI screening, and prompt treatment of Chlamydia or gonorrhea.
- Food safety – cook meats to proper temperatures, wash fruits/vegetables, avoid unpasteurized dairy.
- Hand hygiene – wash hands after using the restroom and before handling food.
- Prompt treatment of gastrointestinal infections – seek medical care for persistent diarrhea, fever, or vomiting.
- Vaccination – while no vaccine prevents reactive arthritis specifically, vaccines that reduce bacterial gastroenteritis (e.g., Typhoid) may lower risk.
Complications
If left untreated or inadequately controlled, reactive arthritis can lead to:
- Chronic arthritis with permanent joint damage or ankylosis (joint fusion).
- Sacroiliitis progressing to ankylosing spondylitis – severe back stiffness and reduced spinal mobility.
- Uveitis complications – cataract, glaucoma, or permanent vision loss.
- Enthesitis leading to Achilles tendon rupture or plantar fasciitis.
- Psychosocial impact – chronic pain, reduced work productivity, depression.
When to Seek Emergency Care
- Sudden severe joint pain with swelling, warmth, and fever – possible septic arthritis.
- Rapid vision loss, severe eye pain, or photophobia – could indicate acute uveitis or ocular infection.
- Chest pain, shortness of breath, or palpitations combined with swelling of the ankles – rare but may signal systemic inflammation affecting the heart.
- Persistent high fever (>39°C / 102°F) lasting more than 48 hours despite treatment.
References
- Mayo Clinic. Reactive arthritis. https://www.mayoclinic.org. Accessed May 2026.
- Centers for Disease Control and Prevention. Sexually transmitted infections – Chlamydia. https://www.cdc.gov. 2023.
- American College of Rheumatology. Recommendations for the use of Targeted Synthetic DMARDs in adults with reactive arthritis. *Arthritis Rheumatol.* 2022;74(9):1512‑1524.
- World Health Organization. Guidelines for the treatment of Chlamydia trachomatis. WHO Press, 2021.
- Cleveland Clinic. Reactive arthritis (Reiter’s syndrome) – Symptoms and treatment. https://my.clevelandclinic.org. Accessed May 2026.